A new study by UC San Francisco found that prostate cancer cases are increasing in California, likely due to a change in ...

Advanced prostate cancer cases are rising sharply in California, outpacing national trends, according to a new study from ...

For men with high-risk prostate cancer and a five-year life expectancy, treatment rose from 17.3% to 46.5%. The researchers concluded that “overtreatment of men with limited LE [life expectancy ...

While most advanced prostate cancer is incurable, treatments can slow or shrink the cancer, reduce symptoms and extend a person's life. Recent advancements in diagnostic techniques and new ...

On Feb. 1, Novartis Pharmaceuticals Canada Inc. announced that the Nova Scotia government is funding Pluvicto injections for ...

The incidence of advanced prostate cancer in California rose markedly in the decade since doctors stopped routinely screening all men for the disease, according to a new study.

that men can have increases of more than two years in their disease trajectory and life expectancy. For advanced prostate cancer in some instances, radiation can be part of a multidisciplinary ...

Researchers have identified two microRNA that may predict which individuals with cancer are at ... More men with limited life expectancy and certain localized prostate cancers have received ...

However, men still trail women in life expectancy. According to the ... diabetes and various forms of cancer, notably prostate and testicular cancer. Cardiovascular disease is dangerous as it ...

A study found no significant HRQOL differences between Erleada-based therapies and ADT plus AAP for advanced castration-sensitive prostate cancer.

The city laid out a series of proposals to reduce cancer deaths by 20 percent, and deaths from heart- and diabetes-related ...